Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Revenue (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Revenue for 2 consecutive years, with $41.9 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 633.06% to $41.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.9 million through Dec 2025, up 698.96% year-over-year, with the annual reading at $62.9 million for FY2025, 698.96% up from the prior year.
  • Revenue for Q4 2025 was $41.9 million at Nuvation Bio, up from $13.1 million in the prior quarter.
  • The five-year high for Revenue was $41.9 million in Q4 2025, with the low at $727000.0 in Q3 2024.